GlobeNewsWire
04 Nov 2025, 21:01 UTC · 50w ago
Verdict
Headline takes no side. We score AVDL +1.00 — strongly bullish.
+1.00strongly bullish
More positive than 99% of ticker scores this week
Which stocks this story touches
More positive than 99% of ticker scores this week
The company reported significant revenue growth, a shift to positive net income, the settlement of litigation, and a pending acquisition at a premium value.
More positive than 69% of ticker scores this week
The company is expanding its portfolio through the strategic acquisition of Avadel Pharmaceuticals.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More positive than 58% of ticker scores this week
The company reached a global settlement and secured future royalty rights on LUMRYZ sales.
More positive than 95% of relationship scores this week
[a_to_b] Alkermes entered into a definitive agreement to acquire Avadel Pharmaceuticals.
More positive than 31% of relationship scores this week
[mutual] Avadel and Jazz entered into a global settlement agreement involving royalty payments and commercialization rights for LUMRYZ.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
1h ago
+14.3%
Price agrees with the score
$21.64 vs $18.94 close before publication (Nov 4) · not market-adjusted
AVDL chart →
